Showing Results for
- Academic Journals (65)
Search Results
- 65
Academic Journals
- 65
-
From:Saudi Journal of Kidney Diseases and Transplantation (Vol. 32, Issue 2) Peer-ReviewedByline: Evgeny. Mezhonov, Iuliia. Vialkina, Kristina. Vakulchik, Sergey. Shalaev The development of acute kidney injury (AKI) in patients during hospitalization worsens the prognosis. The study aimed to estimate the...
-
From:PLoS ONE (Vol. 12, Issue 5) Peer-ReviewedObjective In this study, a systematic evaluation was conducted to estimate the efficacy and safety of ticagrelor for treating acute coronary syndrome (ACS) in general ACS patients and a diabetes mellitus (DM) group....
-
From:Journal of Diabetes Research (Vol. 2021) Peer-ReviewedBackground. Relative to nondiabetic patients, percutaneous coronary intervention (PCI) in patients with diabetes mellitus (DM) is associated with inferior clinical outcomes. We aimed to evaluate the outcomes of...
-
From:Annals of Indian Academy of Neurology (Vol. 25, Issue 4) Peer-ReviewedByline: M. Padma Srivastava, Venugopalan. Vishnu Stroke continues to scourge society in terms of death and disability. In the developing world, the statistics from India narrate an alarming trend of surpassing other...
-
From:CMAJ: Canadian Medical Association Journal (Vol. 193, Issue 28) Peer-ReviewedEnviron 15 000 personnes subissent un pontage aortocoronarien (PAC) chaque annee au Canada1. Selon le Rapport sur les indicateurs de la qualite des soins cardiaques de 2019 de l'Institut canadien d'information sur la...
-
From:Cardiology Research and Practice (Vol. 2020) Peer-ReviewedBackground. The relationship between fasting blood glucose (FBG) and microvascular obstruction (MVO) after primary percutaneous coronary intervention (PCI) remains unclear in nondiabetic patients with ST-segment...
-
From:Neuroscience Bulletin (Vol. 37, Issue 9) Peer-ReviewedAuthor(s): Jiejie Li 1, Zixiao Li 1, Tian-jie Lyu 2, Si Cheng 2, Yuehua Pu 2, Yongjun Wang 1 2 Author Affiliations: (1) grid.411617.4, 0000 0004 0642 1244, Department of Neurology, Beijing Tiantan Hospital, Capital...
-
From:International Journal of Vascular Medicine (Vol. 2020) Peer-ReviewedIntroduction. Diabetes mellitus (DM) and smoking are highly prevalent among Middle Eastern patients admitted with acute coronary syndrome (ACS) or who undergo percutaneous coronary intervention (PCI). Methods. This study...
-
From:PeerJ (Vol. 9) Peer-ReviewedBackground Abdominal aortic aneurysm (AAA) is a disease commonly seen in the elderly. The aneurysm diameter increases yearly, and the larger the AAA the higher the risk of rupture, increasing the risk of death....
-
From:Indian Journal of Anaesthesia (Vol. 63, Issue 12) Peer-ReviewedByline: Ajay. Kumar, Unnati. Bhatia, Barun. Kumar, Ummed. Singh Employment of the transradial approach for percutaneous coronary intervention (PCI) has gained immense popularity amongst interventional cardiologists as...
-
From:Clinical Advisor (Vol. 23, Issue 8)In patients aged <75 years with a body weight of [greater than or equal to] 60 kg, prasugrel 10 mg was associated with significantly lower risk for ischemic complications at 1 year compared with ticagrelor....
-
From:PLoS ONE (Vol. 16, Issue 2) Peer-ReviewedThis study was to compare the efficacy and safety of combined glycoprotein IIb/IIIa inhibitor (GPI) and ticagrelor versus ticagrelor in patients with acute coronary syndrome (ACS). An observational study was conducted...
-
From:Journal of Pakistan Medical Association (Vol. 71, Issue 2)Byline: Zhichao Dong, Hengbo Zhai, Lifei Pan and Bo Zhang Keywords: Antiplatelet therapy, Platelet function, P2Y12 blocker Introduction Co-administering potent P2Y12 receptor antagonist Ticagrelor with aspirin...
-
From:Biomarkers in Medicine (Vol. 5, Issue 1) Peer-ReviewedAuthor(s): James A Shand 1 , Ian BA Menown 1 , Robert F Storey [[dagger]] 2 KEYWORDS : clopidogrel; cytochrome P450 2C19; P2Y12 receptor; platelet inhibitor; ticagrelor Dual antiplatelet therapy with aspirin...
-
From:Family Practice News (Vol. 49, Issue 10)PARIS -- Prasugrel proved superior to ticagrelor in patients with acute coronary syndrome (ACS) in what was hailed as "a landmark study" presented at the annual congress of the European Society of Cardiology. The...
-
From:Cardiology Research and Practice (Vol. 2022) Peer-ReviewedCoronary artery disease (CAD) is one of the leading causes of death in Europe. It is known that atherosclerosis is the primary risk factor of CAD development. MMP-9 is involved in all stages of atherosclerosis and thus...
-
From:Heart India (Vol. 8, Issue 2) Peer-ReviewedByline: Raghuram. Palaparti, Gopala. Koduru, Sudarshan. Palaparti, P. S. Chowdary, Purnachandra. Kondru, Somasekhar. Ghanta, Boochi. Mannuva, Prasad. Maganti, Sasidhar. Yendapalli A 78-year-old male patient with a...
-
From:Diabetology & Metabolic Syndrome (Vol. 14, Issue 1) Peer-ReviewedAlthough physical activity is widely recommended for preventing and treating cardiovascular complications of type 2 diabetes mellitus (T2DM), the underlying mechanisms remain unknown. MicroRNA-126 (miR-126) is an...
-
From:Emergency Nurse (Vol. 19, Issue 7) Peer-ReviewedThe latest version of the European Society of Cardiology guideline on managing patients who present without persistent ST-segment contains recommendations on the use of the new antiplatelet drugs, ticagrelor and...
-
From:CMAJ: Canadian Medical Association Journal (Vol. 194, Issue 48) Peer-ReviewedL'accident ischemique transitoire (AIT) et l'AVC mineur presumes s'observent assez frequemment dans les services d'urgence et en consultation de soins primaires. La prevention de l'AVC secondaire a substantiellement...